Clinical Trials Browser

Phase 2 × reparixin × 90 days × Clear all

NCT05835466 2026-05-06

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

Phase 2 Recruiting

Primary Myelofibrosis